arrow
A

Akhil Kapoor

Homi Bhabha National Institute
H指数:18
被引数:1,287

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut microbiome and immunotherapy in advanced non–small cell lung cancer: a prospective cohort study

肠道微生物组与免疫疗法在晚期非小细胞肺癌中的应用:一项前瞻性队列研究

2026-08-250
OAAI
Role of Gallium 68 fibroblast activation protein inhibitor PET/CT in the initial evaluation of gastric adenocarcinoma: a single-institution retrospective study

68Ga纤维细胞活化蛋白抑制剂PET/CT在胃腺癌初始评估中的作用:一项单中心回顾性研究

2026-02-010
PRE
SAARC Consensus Recommendations for the diagnosis and treatment of non-small-cell lung cancer (NSCLC)

南亚区域合作联盟(SAARC)关于非小细胞肺癌(NSCLC)诊断与治疗的共识建议

2026-01-010
OAAI
Extravasation with systemic anti-cancer directed therapy administration at daycare in a tertiary care oncology centre: Insights from a prospective observational study (EXACT study)

在三级护理肿瘤中心日间护理中心进行全身性抗肿瘤靶向治疗给药时的外渗:来自一项前瞻性观察研究(EXACT研究)的见解

2025-10-010
PRE
Genomic Profiling of Driver Gene Alterations in Patients With Non–Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Center Experience of More Than 1200 Patients

非小细胞肺癌患者驱动基因变异的基因组特征、治疗模式及对生存结局的影响:单中心超过1200例患者的经验

2025-02-110
PRE
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers
2024-07-272
OAAI
Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival
2024-04-012
PRE
Original Article Correlation of the Geriatric Assessment with Overall Survival in Older Patients with Cancer

老年癌症患者的老年评估与总生存期的相关性

2024-01-012
PRE
A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/ 5-fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers
2023-11-010
OA